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ABSTRACT Epidermolysis bullosa simplex associated with late-onset muscular dystrophy 
(EBS-MD) is an autosomal recessive disorder resulting from mutations in the plectin gene. 
The majority of these mutations occur within the large exon 31 encoding the central rod 
domain and leave the production of a low-level rodless plectin splice variant unaffected. To 
investigate the function of the rod domain, we generated rodless plectin mice through con-
ditional deletion of exon 31. Rodless plectin mice develop normally without signs of skin 
blistering or muscular dystrophy. Plectin localization and hemidesmosome organization are 
unaffected in rodless plectin mice. However, superresolution microscopy revealed a closer 
juxtaposition of the C-terminus of plectin to the integrin β4 subunit in rodless plectin kerati-
nocytes. Wound healing occurred slightly faster in rodless plectin mice than in wild-type 
mice, and keratinocytes migration was increased in the absence of the rod domain. The 
faster migration of rodless plectin keratinocytes is not due to altered biochemical properties 
because, like full-length plectin, rodless plectin is a dimeric protein. Our data demonstrate 
that rodless plectin can functionally compensate for the loss of full-length plectin in mice. 
Thus the low expression level of plectin rather than the absence of the rod domain dictates 
the development of EBS-MD.
INTRODUCTION
Plectin is an ∼500-kDa cytoskeletal linker protein of the plakin family 
that is associated with filamentous actin and intermediate filaments 
(IFs). The protein is composed of N- and C-terminal globular do-
mains that are separated from each other by a central α-helical 
coiled-coil rod domain. The N-terminal region contains two cal-
ponin homology domains that form the actin-binding domain 
(ABD). This domain is followed by a plakin domain, which is rich in 
spectrin repeats. The C-terminus of plectin harbors the IF-binding 
site and is characterized by the presence of several plakin repeats 
(Wiche, 1998; Sonnenberg and Liem, 2007).
Plectin is expressed in a variety of tissues, including skin, heart, 
skeletal muscle, liver, and brain (Wiche et al., 1983). Besides its role 
in cross-linking cytoskeletal components, plectin facilitates the at-
tachment of the cytoskeleton to junctional complexes in the plasma 
membrane. One of these junctional complexes is the hemidesmo-
some (HD), a rivet-like structure that mediates adhesion of epithelial 
cells to the underlying basement membrane. Together with integrin 
α6β4, plectin is one of the core components of HDs and is required 
for a proper anchorage of IFs to this cell–matrix junction (Borradori 
and Sonnenberg, 1999). Similarly, plectin is present in other cell–cell 
and cell–matrix junctional complexes, such as desmosomes, Z-lines, 
and focal contacts (Wiche et al., 1983; Seifert et al., 1992; Eger 
et al., 1997). In addition to its role in anchoring the plasma mem-
brane to the cytoskeleton, plectin is involved in the attachment of 
the nucleus to the IF system. This latter activity is mediated by the 
interaction of plectin with the nuclear envelope (NE) protein nesprin-
3α (Ketema et al., 2013). In general, all of the foregoing activities of 
plectin are believed to contribute to the maintenance of cell integ-
rity under situations of mechanical stress.
The importance of plectin in allowing cells to withstand mechani-
cal stress is supported by studies in mice. In 1997, Andrä et al. 
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tion. As shown in Figures 1D and 2A, antibody E398P, which is di-
rected against an epitope in the C-terminus of plectin, reacted with 
a high–molecular weight band, corresponding to full-length plectin, 
in lysates from wild-type and heterozygous mice but not from mice 
with a homozygous deletion of exon 31. Instead, in these lysates, a 
smaller band representing rodless plectin was detected. A band of 
similar size was also observed in lysates from heterozygous and wild-
type mice, although in the latter, the band could be detected only 
after prolonged exposure of the film. Of interest, in mice with a het-
erozygous deletion of exon 31 (Plecfl(Ex31),ΔEx31), the rodless plectin 
isoform is present at significantly higher levels than its full-length 
counterpart (Figures 1D and 2A). Reverse transcriptase quantitative 
PCR (RT-qPCR) analysis on RNA isolated from tail-skin epidermis in-
dicated that the increased level of rodless plectin protein was associ-
ated with a concomitant increase in the expression of the total plec-
tin mRNA content (Figure 2B). In contrast, the expression of plectin 
transcripts containing exon 31 was reduced in the epidermis of mice 
with a heterozygous deletion of exon 31 and absent from the epider-
mis of mice with a homozygous deletion of exon 31 (Figure 2B).
To demonstrate further that the smaller band represents a plectin 
isoform that lacks the central rod domain, we isolated keratinocytes 
from newborn mice homozygous for the floxed exon 31 allele 
(Plecfl(Ex31),fl(Ex31)). By extended culture, we obtained an immortalized 
keratinocyte cell line (OC1) and subsequently removed exon 31 in 
these cells by adenovirus-mediated delivery of Cre-recombinase. 
Clones expressing rodless plectin (clones 1 and 5) were isolated in 
addition to one clone that expressed full-length plectin (clone 12; 
Figure 1E). To demonstrate that clones 1 and 5 indeed lack full-length 
plectin and express rodless plectin instead, we prepared cell lysates 
and immunoblotted them with the antibody 10F6, which recognizes 
an epitope present in the rod domain of plectin (Foisner et al., 1994). 
As expected, this antibody reacted with full-length plectin in the 
original cell line (OC1) and in clone 12 but not in the two clones ex-
pressing the smaller rodless plectin isoform (Figure 1E). In contrast, 
the plectin antibody E398P recognized both full-length and rodless 
plectin (Figure 1E). Similar observations were made in lysates pre-
pared from skin epidermis, for which antibody 10F6 reacted only with 
the larger, full-length plectin isoform and not with the smaller, rodless 
plectin molecule (Figure 2A). In line with our observations in tissue 
lysates, also in the keratinocyte clones, the expression level of rodless 
plectin was found to be higher than that of full-length plectin.
Taken together, these results show that we have successfully 
generated mice that express only the rodless isoform of plectin and 
that expression of this isoform is increased relative to that of the full-
length protein.
Mice expressing rodless plectin do not display any obvious 
abnormalities
The rodless plectin mice were born at Mendelian ratios. In contrast 
to plectin-null mice (Andrä et al., 1997), these mice were viable and 
did not show any signs of skin blistering after birth (Supplemental 
Figure S1). Staining of skin sections from wild-type and rodless plec-
tin mice showed normal basal membrane localization of the HD 
components plectin, integrin α6β4, and BP230 (Figure 3A and Sup-
plemental Figure S1). In addition, the localization of the integrin β1 
subunit was unaffected in the rodless plectin mice. Electron micros-
copy on skin preparations further demonstrated that the morphol-
ogy of HDs in rodless plectin mice was indistinguishable from those 
in wild-type mice (Figure 3B). Furthermore, quantitative analysis of 
HDs revealed no significant differences in the number and size of 
these structures per unit length of basal plasma membrane between 
wild-type and rodless plectin mice (Figure 3, C and D).
Plectin-null mice died within 2–3 d after birth showing severe skin 
blistering due to a reduced number of HDs. In addition, these mice 
displayed myopathy-like abnormalities in both skeletal and cardiac 
muscle (Andrä et al., 1997). Overall these findings were highly remi-
niscent of the defects observed in patients carrying a mutation in 
the plectin gene (PLEC1).
Mutations in PLEC1 can cause three distinct types of the general-
ized blistering disorder epidermolysis bullosa simplex (EBS). The 
inheritance of two of these EBS types is autosomal recessive and 
associated with either late-onset muscular dystrophy (EBS-MD; 
Gache et al., 1996; McLean et al., 1996; Pulkkinen et al., 1996; Smith 
et al., 1996) or pyloric atresia (EBS-PA; Charlesworth et al., 2003; 
Nakamura et al., 2005; Pfendner and Uitto, 2005). In addition, there 
is an autosomal dominant variant called EBS-Ogna, which is caused 
by a site-specific missense mutation in exon 31 encoding the rod 
domain of plectin (Koss-Harnes et al., 2002). EBS-MD is mostly as-
sociated with nonsense or frameshift mutations in exon 31, leading 
to premature termination of translation followed by nonsense-medi-
ated decay of the plectin mRNA. The plectin mutations observed in 
the more severe disease variant EBS-PA are primarily found in the 
exons preceding or following exon 31.
Whereas plectin expression is almost completely lost in EBS-PA 
patients, some EBS-MD patients still express an isoform of plectin 
that lacks the rod domain (Koster et al., 2004; Natsuga et al., 2010). 
Rodless plectin is a normal splice variant of plectin that arises by al-
ternative splicing of exon 31, encoding almost the complete rod 
domain (Elliott et al., 1997). Besides expression in human keratino-
cytes and skeletal muscle (Schröder et al., 2000; Koster et al., 2004), 
rodless plectin transcripts were detected in a variety of rat tissues, as 
well as in mouse brain (Elliott et al., 1997; Fuchs et al., 2005; Stein-
boeck and Kristufek, 2005). Although rodless plectin appears to be 
expressed ubiquitously, its protein level is far less abundant than 
that of the plectin isoforms containing the rod domain (Elliott et al., 
1997). Furthermore, the function of the rodless plectin isoform is 
unknown.
The observation that rodless plectin levels are maintained in the 
milder EBS-MD disease while being absent from the more severe 
EBS-PA disease variant (Koster et al., 2004; Natsuga et al., 2010) 
suggests that rodless plectin influences the severity of the disease 
by functionally compensating for the loss of full-length plectin. To 
investigate the ability of rodless plectin to compensate for the loss 
of full-length plectin, we generated rodless plectin knock-in mice. 
These mice allowed us to study the role of the rodless plectin iso-
form and further determine the function of the plectin rod domain.
RESULTS
Generation of mice expressing rodless plectin
To generate mice lacking full-length plectin but expressing rodless 
plectin instead (hereafter called rodless plectin mice), we used ho-
mologous recombination to introduce two loxP sites on either side 
of exon 31 of the plectin (Plec) gene (Figure 1A). After electropora-
tion of the targeting vector in embryonic stem (ES) cells, homolo-
gous recombination was confirmed by Southern blotting (Figure 
1B). Exon 31 was subsequently removed by the action of Cre-re-
combinase. One of the obtained ES cell clones gave rise to chimeric 
mice that were bred to FVB/N mice to create mice with the desired 
Plec ΔEx31,ΔEx31 genotype. Removal of exon 31 by Cre-recombinase 
was confirmed by PCR on genomic DNA (Figure 1C).
To verify that we indeed had generated rodless plectin mice, we 
performed immunoblot analysis on lysates prepared from skeletal 
muscle and skin epidermis of wild-type mice and mice heterozygous 
(Plecfl(Ex31),ΔEx31) or homozygous (PlecΔEx31,ΔEx31) for the exon 31 dele-
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FIGURE 1: Targeting strategy and molecular analysis of recombinant embryonic stem cells and rodless plectin mice. 
(A) Partial plectin gene structure, targeting construct, and different plectin mutant alleles. Gray boxes represent coding 
exons; gray and black triangles mark loxP and frt sites, respectively. Shown are the locations of the outermost 5′ and 3′ 
restriction sites used to generate the targeting construct and of the BglII and XbaI cleavage sites. The positions of the 
hybridization probe used for Southern blotting and the primers (arrows) used for the analysis of the different mutant 
alleles by PCR are indicated below the wild-type plectin allele. Dotted lines indicate the FLPe- and Cre-specific 
recombination events. (B) Southern blot analysis of four independently targeted ES cell clones. ES cell DNA was 
digested with XbaI (bold), subjected to agarose gel electrophoresis, and transferred to nitrocellulose. The 14.6 and 
11.3-kb fragments corresponding to wild-type and floxed (puroΔtk) alleles, respectively, were detected by hybridization 
with a radiolabeled plectin genomic probe. The asterisk indicates the product of a partially digested wild-type allele. 
(C) PCR analysis of genomic DNA from wild-type, rodless plectin, and heterozygous mice using primers P1–P3. 
(D) Western blot analysis for the presence of full-length (FL) and rodless (RL) plectin in skeletal muscle tissue lysates from 
wild-type, rodless plectin, and heterozygous mice. (E) Western blot analysis of cell lysates from keratinocyte clones 
expressing full-length (OC1, clone 12) or rodless (clones 1 and 5) plectin. Different plectin antibodies recognizing 
epitopes outside (E398P) or within (10F6) the rod domain were used. Actin levels served as a loading control.
Volume 26 July 1, 2015 Rodless plectin and tissue integrity | 2405 
wound closure was faster in these mice. 
Because reepithelialization of the wound 
area is a process that entails both keratino-
cyte migration and hyperproliferation, we 
next investigated whether there was a differ-
ence in keratinocyte proliferation in the epi-
dermal lips of wild-type and rodless plectin 
mice. As a measure of proliferation, we de-
termined the number of Ki67-positive cells, 
which was found to be similar between wild-
type and rodless plectin mice (Figure 4C). 
The observed increase in length of the epi-
dermal lip in the absence of a difference in 
proliferation thus suggests that keratinocyte 
migration is accelerated in the absence of 
the plectin rod domain.
Rodless plectin keratinocytes show a 
slight increase in cell migration
To further investigate the influence of the rod 
domain on keratinocyte migration, we chose 
to remove exon 31 of the plectin gene in 
OC1 cells to avoid clonal divergence. Exon 
31 was deleted by adenovirus-mediated de-
livery of Cre-recombinase, generating OC1/
Cre cells. As a control, OC1 cells were in-
fected with adenovirus encoding green fluo-
rescent protein (OC1/GFP). Western blot 
analysis confirmed that exon 31 was re-
moved, as the OC1/Cre cells showed a de-
crease in the expression level of full-length 
plectin, with a concomitant increase in the expression level of rodless 
plectin (Figure 5A). OC1/GFP and OC1/Cre cells were then sub-
jected to an in vitro scratch assay. Time-lapse imaging of the wounded 
monolayers demonstrated that OC1/Cre keratinocytes consistently 
migrated faster than control OC1/GFP cells (Figure 5B). Although the 
difference in wound closure was not significant (p = 0.41; Figure 5C), 
there was a clear trend. Similar to the in vivo wound-healing experi-
ment, wound closure in the in vitro scratch assay is also dependent 
on both cell migration and proliferation. To determine whether the 
enhanced wound healing could be caused by increased proliferation 
of the OC1/Cre cells, we followed the proliferation of these two cell 
lines over time. Because the rate of proliferation of OC1/GFP and 
OC1/Cre cells was similar (Figure 5D), our results suggest that the 
increased wound closure observed with OC1/Cre cells is due to an 
increase in cell migration in the absence of the plectin rod domain.
Hemidesmosome composition, cytoskeletal organization, 
and integrin β4 phosphorylation are unaffected in rodless 
plectin keratinocytes
To investigate whether the increased migration speed of rodless 
plectin keratinocytes was due to changes in the composition of 
HDs, we studied the hemidesomosomal structures of keratinocyte 
clones expressing full-length or rodless plectin. Similar to our obser-
vations in mouse skin, staining of the keratinocyte clones showed a 
clear colocalization of the integrin β4 subunit with plectin and BP230 
in rodless plectin keratinocytes (Figure 6A). Furthermore, the cell 
surface levels of integrins β4 and α6 were either similar between the 
two cell clones or slightly increased in the keratinocyte clone ex-
pressing rodless plectin (Figure 6B). These results suggest that the 
absence of the rod domain in plectin has no major effect on the 
composition of HDs or the expression of integrin subunits.
Given that EBS-MD patients begin to develop symptoms of mus-
cular dystrophy in the first decades of their life (Fine et al., 1989; 
McLean et al., 1996; Pulkkinen et al., 1996), we followed the rodless 
plectin mice over time for indications of muscle weakness or devel-
opment of muscular dystrophy. Moreover, to trigger the develop-
ment of muscular dystrophy, we increased the strain applied on the 
muscles by letting the mice run on treadmills for a total of 4 wk. 
During this experiment, the mice were stimulated to run 1 h each 
day for 5 d/wk. Of interest, even after a follow-up period of 2 yr, the 
rodless plectin mice did not show evidence of muscular dystrophy at 
the macroscopic level or at the histological level (unpublished data). 
Furthermore, staining of skeletal muscle sections showed normal 
localization of plectin, dystroglycan, and integrin β1 in skeletal mus-
cle of rodless plectin mice (Figure 3E).
Hence rodless plectin mice develop normally and do not show 
signs of skin blistering, muscular dystrophy, or other abnormalities. 
Moreover, these findings do not depend on the genetic background 
of the FVB/N mice, as backcrossing the mice into a C57Bl/6 back-
ground also failed to reveal any abnormalities.
Wound healing is faster in rodless plectin mice
Although HDs appear to be normally assembled in rodless plectin 
mice, the absence of the central rod domain in plectin might influ-
ence the dynamic turnover of HDs, which is required for keratinocytes 
to migrate during wound healing. To investigate possible effects of 
the plectin rod domain on wound healing, we inflicted four full-thick-
ness excision wounds, two on each side of the dorsal midline, on the 
back of wild-type and rodless plectin mice. The rate of wound healing 
was subsequently determined by measuring the length of the epider-
mal lip at day 3 after wounding (Figure 4A). In rodless plectin mice, 
the epidermal lip was longer (Figure 4B; p < 0.01), suggesting that 
FIGURE 2: The expression level of rodless plectin protein and mRNA is increased in the 
epidermis of rodless plectin mice. (A) Lysates of the tail- and back-skin epidermis of wild-type 
(WT/WT), rodless plectin (RL/RL), and heterozygous (WT/RL) mice were analyzed by Western 
blot for expression of the indicated proteins. Two different antibodies for plectin were used; 
E398P has its epitope in the C-terminus of plectin, and 10F6 recognizes the rod domain. 
(B) Total RNA was isolated from the tail-skin epidermis of two wild-type (WT/WT), three rodless 
plectin (RL/RL), and three heterozygous (WT/RL) mice. The relative mRNA expression of total 
plectin and plectin transcripts containing the rod domain (Ex29-Ex31) was determined by 
RT-qPCR in relation to β-actin. Graph shows the mean and SEM of two independent 
experiments.
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2010). To investigate whether the phosphor-
ylation-dependent breakdown of HDs is al-
tered in the rodless plectin keratinocytes, 
we deprived keratinocytes expressing full-
length or rodless plectin of growth factors 
and subsequently stimulated them with epi-
dermal growth factor (EGF). No difference in 
the kinetics of phosphorylation of β4 at 
S1356 and S1364 was observed between 
the two types of keratinocytes (Figure 6C).
Besides being a component of HDs, 
plectin also mediates cross-linking of IFs 
and filamentous actin (F-actin). Moreover, 
results of studies with cell cultures derived 
from plectin-null mice have revealed a role 
of plectin as an important regulator of actin 
cytoskeleton dynamics (Andrä et al., 1998). 
However, no obvious differences in the or-
ganization of the IF and actin cytoskeleton 
were observed between keratinocyte clones 
expressing either full-length or rodless plec-
tin (Figure 6D).
Taken together, these results indicate 
that the absence of the plectin rod domain 
has no effect on the behavior of HDs or the 
organization of the cytoskeleton.
Closer juxtaposition of the C-terminus 
of plectin and β4 in rodless plectin 
keratinocytes
To investigate the localization of plectin and 
integrin β4 in more detail, we stained kerati-
nocyte clones expressing full-length or rod-
less plectin with antibodies against the ex-
tracellular domain of integrin β4 and the 
C-terminal domain of plectin, which harbors 
the IF-binding site. Superresolution micros-
copy (GS-DIM) showed that both plectin 
and integrin β4 are associated with filamen-
tous, probably cytokeratin, structures. 
Within these structures, the distance be-
tween integrin β4 and the antibody-labeled 
C-terminus of plectin was noticeably smaller 
in keratinocyte clones expressing rodless 
plectin compared with those expressing full-
length plectin. This was observed by both 
visual inspection and quantitative assess-
ment (Figure 7, A and B). Thus the absence 
of the plectin rod domain results in closer 
juxtaposition of the β4 extracellular domain 
to both the C-terminus of plectin and the 
cytokeratin network.
Rodless plectin is recruited to the 
nuclear envelope by nesprin-3
Plectin is believed to form dimers through 
intermolecular interactions of its central rod 
domain (Foisner and Wiche, 1987; Foisner et al., 1991; Wiche et al., 
1991; Wiche, 1998; Green et al., 1992; Uitto et al., 1996). Moreover, 
dimerization and/or oligomerization are believed to be essential for 
the function of plectin (Walko et al., 2011). In fact, we previously 
suggested that rod domain–mediated dimerization of plectin is 
The dissociation of the complex of plectin and integrin α6β4 is 
considered to be an essential first step in the process of keratinocyte 
migration and is controlled through phosphorylation of the integrin 
β4 subunit at multiple residues, including serine residues 1356 and 
1364 (Rabinovitz et al., 2004; Wilhelmsen et al., 2007; Frijns et al., 
FIGURE 3: Rodless plectin mice show normal plectin localization and HD organization. 
(A) Frozen sections of the skin of wild-type and rodless plectin mice were double labeled for the 
indicated proteins. Nuclei were counterstained with DAPI. Scale bar, 20 μm. (B) Electron 
microscopy images of the skin of wild-type and rodless plectin mice showing hemidesmosomal 
structures. Scale bars, 200 nm. (C, D) Quantification of the results shown in B. The number of 
HDs per length unit of plasma membrane (C) and size of HDs (D) was quantified in two wild-type 
and two rodless plectin mice. Values represent the mean and SD. n.s., not significant. (E) Frozen 
sections of skeletal muscle of wild-type and rodless plectin mice were stained for plectin and 
integrin β1 or dystroglycan. Nuclei were counterstained with DAPI. Scale bars, 20 μm.
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To determine whether the rod domain is also dispensable for peri-
nuclear localization of plectin in Sertoli cells, we double-labeled 
sections of the testis of a rodless plectin mouse for nesprin-3 and 
plectin. Nesprin-3 was present at the NE of Sertoli cells in both 
wild-type and rodless plectin mice (Figure 8B). In line with our in 
vitro data, rodless plectin was recruited to the nuclear perimeter 
of Sertoli cells (Figure 8B), suggesting that the rod domain is not 
required for the in vivo localization of plectin at the NE. This is 
further supported by the observation that vimentin was still found 
to be associated with the nuclear perimeter in Sertoli cells of rod-
less plectin mice (Figure 8C). However, the amount of rodless 
plectin in the nuclear vicinity appeared to be somewhat reduced 
compared with that observed in wild-type Sertoli cells, suggest-
ing that the recruitment of rodless plectin to the NE may be less 
efficient.
Rodless plectin can still form dimers
Because our rodless plectin mice do not display any gross abnor-
malities and show a normal localization pattern of plectin, we 
required for its interaction with nesprin-3α at the NE (Ketema et al., 
2007). Because the generation of rodless plectin mice and the isola-
tion of keratinocyte clones expressing either full-length or rodless 
plectin provides us with better tools to study the function of the 
plectin rod domain, we further investigated whether the plectin rod 
domain is required for the interaction of plectin with nesprin-3α. To 
this end, we stably transfected cell clones expressing full-length 
(clone 12) or rodless (clone 1) plectin with GFP-nesprin-3α or GFP-
nesprin-3β. Consistent with previous findings, both nesprin-3 iso-
forms localized at the NE of the keratinocyte clones, but only over-
expression of GFP-nesprin-3α led to the recruitment of full-length 
plectin to the NE (Figure 8A; Wilhelmsen et al., 2005). Surprisingly, 
rodless plectin was found to localize at the NE upon overexpression 
of GFP-nesprin-3α (Figure 8A). Hence these results indicate that 
nesprin-3α-mediated recruitment of plectin to the NE does not de-
pend on the presence of the plectin rod domain.
In addition to overexpression studies, we previously showed 
that localization of plectin at the nuclear perimeter of Sertoli cells 
is dependent on the presence of nesprin-3 (Ketema et al., 2013). 
FIGURE 4: Wound healing is accelerated in rodless plectin mice. (A) Hematoxylin and eosin–stained sections depicting 
wound closure in wild-type and rodless plectin mice on day 3 after wounding. The outline of the epidermal lip is 
indicated by a dotted line. Scale bar, 100 μm. (B) Boxplot showing the length of the epidermal lip in wild-type and 
rodless plectin mice on day 3 after wounding. The data represent 27 wild-type (99 wounds) and 22 rodless plectin mice 
(81 wounds) pooled from four independent experiments. Statistical significance was determined using the Student’s 
t test. *p < 0.01. (C) Cell proliferation in the epidermal lip was quantified by determining the average number of Ki67+ 
cells/mm in the wounds of four wild-type and four rodless plectin mice. Error bars represent the SD.
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With increasing concentrations of DSP, we observed a shift from mo-
nomeric full-length plectin to a higher–molecular weight protein 
product (Figure 9B). A similar shift was seen for rodless plectin 
(Figure 9B). When the same samples were run under reducing con-
ditions to disrupt the disulfide bonds, only the monomers of full-
length and rodless plectin were visible (Figure 9B).
In addition to gel filtration chromatography and chemical cross-
linking, whole-cell lysates of the keratinocyte clones were also sub-
jected to blue native PAGE (BN-PAGE). Both full-length and rodless 
plectin migrated as a single molecular weight species under native 
conditions (Figure 9C). When urea or a combination of SDS and urea 
was added to the lysates, the plectin bands migrated faster and cor-
responded in size to the plectin monomers obtained after lysis of 
the cells with RIPA lysis buffer (Figure 9C). Of note, the efficiency by 
which plectin, and in particular rodless plectin, was solubilized was 
greatly increased by the addition of the neutral chaotropic agent 
urea. This may indicate that rodless plectin is more stably bound to 
other proteins (e.g., the actin cytoskeleton) than full-length plectin. 
wondered whether the capacity to form plectin dimers was affected 
by the absence of the rod domain.
Plectin dimerization was initially investigated by gel filtration 
chromatography. Whole-cell lysates of keratinocyte clones express-
ing full-length (OC1) or rodless (clone 1) plectin were applied on 
Superose 6 columns, after which the individual fractions were ana-
lyzed by immunoblotting for the presence of plectin. The majority of 
full-length plectin is found in fraction 1 and eluted in the void vol-
ume of the column (Figure 9A). In contrast, rodless plectin is primar-
ily present in fractions 4 and 5 (Figure 9A). The 699-kDa marker 
protein thyroglobulin also eluted in fraction 5 (Figure 9A), suggest-
ing that rodless plectin is part of a larger complex of ∼700 kDa, pos-
sibly consisting of a rodless plectin dimer.
To further investigate the potential dimerization of rodless plec-
tin, we performed chemical cross-linking experiments. Lysates of 
keratinocyte clones expressing full-length (OC1) or rodless (clone 1) 
plectin were incubated with the chemical cross-linking reagent di-
thiobis-succinimidyl propionate (DSP) in different concentrations. 
FIGURE 5: Keratinocytes expressing rodless plectin show a slight but consistent increase in cell migration. (A) OC1 
Plecfl(Ex31),fl(Ex31) keratinocytes (OC1) were infected with adenoviruses expressing either GFP (OC1/GFP) or Cre-
recombinase (OC1/Cre). Lysates of OC1, OC1/GFP and OC1/Cre were analyzed by Western blot for expression of the 
indicated proteins. The 10F6 and E398P plectin antibodies recognize epitopes in the rod domain and C-terminus, 
respectively. Tubulin levels served as a loading control. (B) Phase contrast images of OC1/GFP and OC1/Cre at 0, 7, 13, 
and 20 h after wounding. Wound edges are marked in white. Scale bar, 50 μm. (C) Rate of wound closure in OC1/GFP 
and OC1/Cre cells. Values represent the mean ± SEM of three independent experiments. n.s., not significant. 
(D) Proliferation of OC1/GFP and OC1/Cre cells. Error bars indicate the SD over two independent experiments.
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Hence it will be less efficiently recovered when native conditions 
(Triton X-100) are used for cell lysis. Furthermore, the finding also 
suggests that samples obtained under native conditions primarily 
contain unbound plectin.
To understand the mechanisms that drive self-association of rod-
less plectin, we analyzed the protein sequence around the region 
coded by exon 31 for additional coiled-coil signatures. A segment 
of ∼140 residues encoded by the beginning of exon 32 of mouse 
and human plectin is predicted to form a coiled-coil that is likely to 
mediate homodimerization of rodless plectin (Figure 10). This addi-
tional coiled-coil has also been described in rat plectin (Steinboeck 
and Kristufek, 2005).
In summary, the experiments described here all suggest that 
both full-length and rodless plectin are capable of dimerization. Be-
cause of the elongated nature of full-length plectin and the lack of 
suitable high-range molecular weight marker proteins, we were 
unable to determine whether rodless plectin only forms dimers or 
also forms higher-order oligomers.
DISCUSSION
In this study, we generated mice lacking full-length plectin but ex-
pressing rodless plectin to investigate the function of the plectin rod 
domain. Mice expressing the rodless plectin molecule developed 
normally without signs of skin blistering or muscular dystrophy. The 
structure and composition of HDs were unaltered, and even plectin 
dimerization occurred normally. The only differences from wild-type 
mice were that wound healing occurred slightly faster and, in the 
absence of the rod domain, the C-terminus of plectin was more 
closely juxtaposed to the integrin β4 extracellular domain. These 
observations suggest that rodless plectin and full-length plectin 
have largely redundant functions.
Our observation that rodless plectin is able to functionally com-
pensate for the loss of full-length plectin in mice is in line with the 
differences in severity of the disease in EBS-MD and EBS-PA pa-
tients. The expression of all plectin isoforms is affected in the more 
severe EBS-PA disease variant, whereas the expression of rodless 
plectin is maintained in EBS-MD patients with a relatively moderate 
phenotype (Natsuga et al., 2010). However, in contrast to our mouse 
model and despite the expression of rodless plectin, EBS-MD pa-
tients still develop the disease. This is most likely due to a difference 
in the expression level of rodless plectin in EBS-MD patients and our 
rodless plectin mice.
Under normal circumstances, rodless plectin constitutes only a 
minor proportion of total plectin. In the mouse brain, the transcript 
levels of plectin variants lacking the rod domain were ∼20-fold lower 
than those of plectin variants containing the rod domain (Fuchs 
et al., 2005). Similar observations were made in human keratino-
cytes, for which the ratio of full-length to rodless plectin was esti-
mated to be 21.3:1 (Natsuga et al., 2010). In EBS-MD patients, only 
the expression of rodless plectin is maintained. This would imply 
that the total expression level of plectin is reduced to ∼5% of the 
levels observed in healthy individuals. This is true not only in kerati-
nocytes, but also in other tissues and cell types, although the actual 
percentage that rodless plectin contributes to the total amount of 
plectin varies greatly between cell types (Natsuga et al., 2010).
Although we expected that in rodless plectin mice the rodless 
plectin protein and mRNA would be expressed at levels similar to 
those of their full-length counterparts, RT-qPCR and immunoblot 
analyses revealed that this is not the case. Instead, at both the RNA 
and protein levels, the expression of rodless plectin was significantly 
higher than that of full-length plectin. However, we cannot formally 
exclude that the higher level of rodless plectin protein expression 
compared with full-length plectin is (partially) due to a lower transfer 
efficiency of the full-length protein during Western blotting. 
Nevertheless, if rodless plectin is expressed to a higher level than 
full-length plectin, this may be an important factor contributing to 
the efficiency by which this protein functionally compensates for the 
loss of full-length plectin in the rodless plectin mice.
Given that the expression level of rodless plectin appears to be 
the main discriminating factor between EBS-MD patients and our 
mouse model, it is tempting to speculate that an increase in the ex-
pression level of rodless plectin could alleviate the symptoms of EBS-
MD patients. The vast majority of EBS-MD–causing mutations are 
found in exon 31 encoding the rod domain (Pfendner et al., 2005). 
These mutations ultimately result in nonsense-mediated decay of 
rod-containing plectin transcripts. In contrast, rodless plectin tran-
scripts are maintained as the site of mutation is spliced out. If splicing 
of exon 31 could be stimulated, more rodless plectin transcripts could 
be formed, resulting in an increase in the level of rodless plectin pro-
tein. Similar so-called exon-skipping strategies are being developed 
for treatment of neuromuscular diseases (Touznik et al., 2014). It will 
be interesting to see whether such strategies can be adapted to the 
treatment of EBS-MD patients with mutations in exon 31.
Plectin binds to the integrin β4 subunit through its N-terminal 
ABD and plakin domain (Rezniczek et al., 1998; Geerts et al., 1999; 
Koster et al., 2004; de Pereda et al., 2009), whereas its C-terminal 
domain harbors a binding site for IFs (Nikolic et al., 1996). Our find-
ing that in rodless plectin keratinocytes, as compared with keratino-
cytes expressing full-length plectin, the C-terminus of plectin is 
more closely juxtaposed to the β4 extracellular domain is in line 
with the smaller size of the rodless plectin molecule and the pres-
ence of binding sites for IFs and the integrin β4 subunit on opposite 
ends of the central rod domain. A closer juxtaposition of the C-ter-
minus to β4 will allow IFs to become more closely localized to β4 
and thus to plasma membrane-associated HDs. However, appar-
ently this has no consequence for the overall structure and function 
of HDs.
The accelerated wound healing in rodless plectin mice was as-
sociated with an increased migration speed of rodless plectin kera-
tinocytes. This increase in cell migration cannot be explained by 
changes in the structure or composition of HDs, as these were iden-
tical to those in cells expressing full-length plectin. An alternative 
explanation might be found in an altered actin dynamics. It was pre-
viously demonstrated that plectin is involved in the regulation of 
short-term actin rearrangements (Andrä et al., 1998). One can pos-
tulate that the shorter distance between rodless plectin and its bind-
ing partners can make actin rearrangements more dynamic, which 
can ultimately lead to faster cell migration.
Recently, Walko et al. (2011) showed that the central coiled-coil 
rod domain of plectin is a dimer that can self-associate further into 
higher-order oligomers. Moreover, they suggested that rod do-
main–mediated oligomerization is required for HD stability. Al-
though the rod domain may certainly contribute to the dimerization 
and oligomerization of plectin, the present study shows that it is not 
essential for plectin dimerization. Rod domain–independent dimer-
ization of plectin is not unexpected, as plectin has been shown to 
self-associate via its globular end domains (Foisner and Wiche, 
1987). In fact, the plectin ABD has been found to form dimers 
(Fontao et al., 2001). Moreover, the plakin domain of plectin con-
tains spectrin repeats, which are also capable of dimerization (Le 
Rumeur et al., 2012). Either or both of these plectin domains could 
mediate dimerization in our rodless plectin mice. Finally, rodless 
plectin contains a coiled-coil encoded by the initial segment of exon 
32, which could form dimers with a similar organization to that of the 
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FIGURE 6: HD composition, cytoskeletal organization, and integrin β4 phosphorylation are normal in rodless plectin 
keratinocytes. (A) Wild-type (clone 12) and rodless (clone 16) plectin keratinocytes were grown on collagen I–coated 
coverslips. Cells were fixed in paraformaldehyde and stained for integrin β4 and either plectin (top) or BP230 (bottom). 
Nuclei were counterstained with DAPI, and cells were analyzed by confocal microscopy. Scale bars, 20 μm. (B) The cell 
surface expression of integrin β4 (top) and integrin α6 (bottom) was investigated by flow cytometry in wild-type 
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erating more binding sites in the cytoplasm, which prevented their 
localization at the NE (Ketema et al., 2007). The finding that overex-
pression of nesprin-3α in an EBS-MD patient cell line only led to 
limited recruitment of rodless plectin to the NE (Ketema et al., 2007) 
may be explained by the relatively low level of expression of the 
rodless plectin variant in the patient cells (Koster et al., 2004). 
Hence the combination of a low expression level and the presence 
of multiple plectin binding partners could cause the amount of rod-
less plectin at the NE to be below our detection limit. Because 
full-length variants, albeit with a shorter spacing between the N- 
and C-terminal regions.
We previously suggested that rod domain–mediated dimeriza-
tion of plectin is required for its recruitment to the NE (Ketema et al., 
2007). However, the present experiments indicate that rodless plec-
tin is recruited to the NE in a normal manner. The cause for this 
discrepancy may lie in the fact that the expression of short plectin 
fragments containing the ABD but lacking the central rod domain in 
cells had a stabilizing effect on the actin cytoskeleton, thereby gen-
FIGURE 7: Close juxtaposition of plectin and integrin β4 in rodless plectin keratinocytes. (A) Wild-type and rodless 
plectin keratinocytes were double labeled with antibodies against the C-terminus of plectin (P1) and the extracellular 
domain of the integrin β4 subunit (mAb 346-11A). Superresolution microscopy images show plectin and integrin β4 
associated with filamentous, probably cytokeratin, structures. The areas depicted by the white rectangles are enlarged 
and displayed in the middle. Scale bars, 500 nm. (B) Quantification of the distance between the antibody-labeled plectin 
and integrin β4 molecules in filamentous structures. The graphs indicate the integrated intensity distributions of the β4 
and plectin pixels as a function of their distance from the center of a line drawn through a filamentous network of 
plectin pixels. The broader distribution pattern of β4 seen with full-length plectin is consistent with the C-terminal 
domain of plectin being more spatially separated from the β4 extracellular domain in keratinocytes that express 
full-length plectin as compared with those expressing the rodless plectin variant.
(clone 12) and rodless (clone 16) plectin keratinocytes. Gray shading indicates cells incubated with only secondary 
antibody. (C) Time course of EGF-induced phosphorylation of integrin β4 at S1356 and S1364 in wild-type (clone 12) and 
rodless (clone 16) plectin keratinocytes. Cells were deprived of growth factors for 24 h and subsequently stimulated 
with EGF for the indicated times. Cell lysates were analyzed by Western blot for expression of the indicated proteins. 
(D) Wild-type (clone 12) and rodless (clone 16) plectin keratinocytes were treated as described in A and stained for 
plectin, integrin β4, and either F-actin (top) or keratin 14 (bottom). Cells were subsequently analyzed by confocal 
microscopy. Scale bars, 20 μm.
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plectin fragments II and III were P6/P7 and P8/P9, respectively. After 
linearization with PvuI, 80 μg of the targeting construct was electro-
porated into 129/Ola-derived embryonic stem cells. Colonies resis-
tant to 3.3 μM puromycin were screened for the desired homolo-
gous recombination by Southern blotting, using a probe generated 
from a digest of plectin fragment III with KpnI. The puroΔtk cassette 
flanked by frt sites was removed by transient transfection of pFLPe 
(Rodriguez et al., 2000). Colonies resistant to 5 μM ganciclovir were 
selected, and exon 31 of plectin was subsequently deleted by tran-
sient transfection of Cre-expression plasmid pOG231 (O’Gorman 
and Wahl, 1997). One recombinant ES cell clone harboring the plec-
tin rodless allele and one harboring the plectin floxed allele were 
injected into mouse C57Bl/6 blastocysts, which were transferred to 
mothers of the same strain. The chimeric male offspring was mated 
with FVB/N females. Agouti coat–colored offspring of the chimeric 
mouse harboring the plectin rodless allele were screened for the 
absence of exon 31 by PCR analysis of tail DNA with primers P1–P3 
(Table 1). Heterozygous mice were intercrossed, and littermates 
were analyzed. To isolate the tail-skin epidermis, the tail was cut, 
and an incision was made along the length of the tail. After removal 
of the bone tissue, the skin was stretched on a card, cut into 1-cm-
wide pieces, and incubated in 5 mM EDTA in phosphate-buffered 
saline (PBS) for 4 h at 37°C with slow shaking. The epidermis was 
neither of these problems occurred in our rodless plectin mice, we 
could clearly demonstrate in this study that the rod domain is not 
essential for the interaction of plectin with nesprin-3α.
In summary, with the generation of a rodless plectin knock-in 
mouse model, we could demonstrate that rodless plectin can func-
tionally compensate for the loss of full-length plectin in mice. This 
observation suggests that the expression level of plectin rather than 
the absence of the plectin rod domain is the main determinant in 
the development of EBS-MD. Future studies are required to investi-
gate whether exon-skipping techniques can be used in EBS-MD 
patients to increase the expression level of rodless plectin, thereby 
alleviating their symptoms.
MATERIALS AND METHODS
Generation of rodless plectin mice
A BAC clone comprising exons 25–32 of plectin was isolated from a 
129S7AB2.2 library (Sanger Institute, Cambridge, UK). A 10.4-kb 
fragment of genomic plectin was cloned in three steps into pFlexi-
ble, which is a generic targeting vector containing the selectable 
marker puroΔtk and loxP and frt recombination sites (van der Wey-
den et al., 2005), using sequence-specific primers containing restric-
tion site tags (Table 1). Fragment plectin I was amplified with Pwo 
polymerase using primers P4 and P5. Primers for the amplification of 
FIGURE 8: Rodless plectin is recruited to the nuclear envelope by nesprin-3α. (A) Keratinocytes expressing full-length 
(clone 12) or rodless (clone 1) plectin were stably transfected with GFP-nesprin-3α or GFP-nesprin-3β, stained for 
plectin, and analyzed by confocal microscopy. Arrowheads indicate recruitment of plectin to the nuclear envelope. Scale 
bar, 10 μm. (B, C) Frozen sections of the testes of 2-mo-old wild-type (WT) and 3-mo-old rodless plectin (rodless) mice 
were stained for the indicated proteins. Nuclei were counterstained with DAPI. Scale bar, 20 μm.
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subsequently peeled from the dermis in the direction of the hair 
follicles.
RNA isolation and RT-qPCR
RNA was isolated from 100 mg of tail-skin epidermis using TRIzol 
reagent (Ambion Life Technologies, Carlsbad, CA) according to the 
manufacturer’s instructions. cDNA was synthesized from 3 μg of to-
tal RNA using the First Strand cDNA Synthesis Kit (Thermo Scientific, 
Rockford, IL) with oligo(dT) primers. Primers were designed using 
Primer Express software (Applied Biosystems, Foster City, CA). The 
following primers were used: 5′-AGT ACCGGGAGCTTGTGTTG-3′ 
and 5′-TGGCACCATAGGATCTCA ATC-3′ for total plectin (product 
size, 148 base pairs), 5′-CAGCTGATCACGTACAAGGC-3′ and 
5′-GTCCACTGCTGCCTCCTC-3′ for plectin Ex29-Ex31 (product 
size, 378 base pairs), and 5′-GCTCTTTTCCAGCCTTCCTT-3′ and 
5′-CTTCTGCATCCTGTCAGCAA-3′ for β-actin (product size, 168 
base pairs). RT-qPCR was performed in an ABI Prism 7500 Real Time 
PCR System (Applied Biosystems) using SYBR Advantage qPCR Pre-
mix (Clontech, Mountain View, CA) and the thermocycler conditions 
as recommended by the manufacturer. The mRNA relative quantities 
FIGURE 9: The rod domain is not essential for dimerization of plectin. (A) Cell lysates of keratinocytes expressing 
full-length (OC1) or rodless (clone 1) plectin were subjected to gel filtration over Superose 6. The collected fractions 
(0–9) were analyzed by Western blot for the presence of plectin. Fractions containing the void and the 669-kDa marker 
protein thyroglobulin are indicated. L, lysates prior to gel filtration. (B) Cell lysates of keratinocytes expressing full-
length (FL, OC1) or rodless (RL, clone 1) plectin were left untreated (–), mock treated with dimethyl sulfoxide, or 
incubated with increasing concentrations of the chemical cross-linker DSP. After cross-linking, the lysates were 
separated by SDS–PAGE under reducing and nonreducing conditions and immunoblotted for plectin. (C) Lysates of 
keratinocytes expressing full-length (FL, OC1) or rodless (RL, clone 1) plectin were subjected to BN-PAGE and 
immunoblotted for plectin. Native samples were compared with samples containing urea and/or SDS and samples 
generated using RIPA lysis buffer. For urea-containing samples, only one-third of the sample volume was loaded on gel. 
Single and double arrowheads indicate plectin monomers and dimers, respectively. Closed arrowheads, full-length 
plectin; open arrowheads, rodless plectin.
FIGURE 10: Rodless plectin is predicted to form coiled-coil 
structures. Predicted probability of coiled-coils calculated with the 
programs Marcoil, Coils, and Paircoil2 in the region of rodless plectin 
encoded by exons 30 and 32. Residue numbers correspond to human 
plectin (Uniprot Q15149). The exons that code this region are 
indicated at the top.
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of ecotropic Phoenix cells. Keratinocyte clones were subsequently 
infected with the recombinant virus by the DOTAP (Roche, India-
napolis, IN) method, selected on Zeocin (Invitrogen, 
Carlsbad, CA), and sorted for the expression of GFP by fluores-
cence-activated cell sorting.
In vivo wound healing and proliferation experiments
Wound-healing experiments were essentially performed as de-
scribed previously (Hamelers et al., 2005). In short, adult mice were 
anesthetized and shaved, and two full-thickness excision wounds of 
4-mm diameter were cut with small scissors on either side of the 
dorsal midline. Complete wounds including surrounding tissue 
were excised at day 3 after injury. Paraffin sections across the middle 
of the wounds were stained with hematoxylin and eosin or anti-Ki67 
antibodies. Sections were scanned on a ScanScope XT (Aperio, 
Vista, CA). Wound closure was determined by measuring the length 
of the neo-epidermis. Wounds were inflicted in four independent 
experiments on a total of 27 wild-type and 22 rodless plectin mice. 
To analyze proliferation, the number of Ki67+ cells/mm was scored 
in the neo-epidermis of wounds from four wild-type and four rodless 
plectin mice. Comparisons were made using the Student’s t test.
Antibodies
The rat monoclonal antibody (mAb) against integrin α6 (GoH3), the 
rabbit polyclonal antibody (pAb) against the first pair of FNIII re-
peats of integrin β4, the rabbit pAbs against phosphorylated integ-
rin β4 (S1356 and S1364), and the rabbit pAb against nesprin-3 have 
been described previously (Sonnenberg et al., 1987; Wilhelmsen 
et al., 2005, 2007; Frijns et al., 2010). The rabbit pAb AP83 against 
β-dystroglycan and the rat mAb MB1.2 against integrin β1 were 
kindly provided by Kevin Campbell (Howard Hughes Medical Insti-
tute, Iowa City, IA; Ervasti and Campbell, 1991) and Bosco Chan 
(University of Western Ontario, London, Canada), respectively. 
Guinea pig antibody P1 raised against the C-terminal plakin-repeat 
domain C of plectin was a kind gift from Harald Herrmann (German 
Cancer Research Center, Heidelberg, Germany; Stegh et al., 2000). 
The human mAbs 5E and 10D against human BP230 was generously 
provided by Takashi Hashimoto (Kurume University, Kurume, Japan; 
Hashimoto et al., 1993). The rabbit pAb against the γ2 chain of Ln-
332 was a kind gift of Takako Sasaki (Oita University, Oita, Japan). 
Rabbit anti-vimentin was provided by Frans Ramaekers (Maastricht 
University Medical Center, Maastricht, Netherlands). Other primary 
antibodies used in this study were anti-plectin rabbit mAb (E398P; 
ab32528; Abcam, Cambridge, MA), anti-plectin mouse mAb (10F6; 
sc-33649; Santa Cruz Biotechnology, Dallas, TX), anti-plectin goat 
pAb (C-20; sc-7572; Santa Cruz Biotechnology), anti–integrin β4 rat 
mAb (346-11A; BD Biosciences, San Jose, CA), anti–keratin 14 rab-
bit pAb (Covance, Emeryville, CA), anti-Ki67 rabbit pAb (Monosan, 
Uden, The Netherlands), anti–phospho-Erk1/2 (T202/Y204) rabbit 
mAb (197G2; Cell Signaling Technology, Danvers, MA), anti-GFP 
goat pAb (T-19; sc-5384; Santa Cruz Biotechnology), anti-actin 
mouse mAb (clone C4; Chemicon International, Temecula, CA), 
anti–α-tubulin mouse mAb (B-5-1-2; Sigma-Aldrich), and PE-labeled 
anti-integrin α6 rat mAb (GoH3; eBiosciences, San Diego, CA). The 
following secondary antibodies were used: goat anti-rat fluorescein 
isothiocyanate (Rockland Immunochemicals, Limerick, PA), donkey 
anti-rabbit horseradish peroxidase (HRP; GE Healthcare, Little 
Chalfont, UK), goat anti-mouse HRP (GE Healthcare), sheep anti-
mouse HRP (GE Healthcare), sheep anti-human HRP (GE Health-
care), and rabbit anti-goat HRP (Zymed, San Francisco, CA). Goat 
anti-guinea pig Alexa Fluor 488, goat anti-human Alexa Fluor 488, 
goat anti-rat Texas red, goat anti-rabbit Texas red, donkey anti-goat 
were obtained using the 2−ΔΔCT method and normalized against β-
actin. At least two independent biological samples were analyzed 
per genotype.
Keratinocyte isolation and transduction
Primary keratinocytes were isolated from newborn (1- to 3-d-old) 
Plecfl(Ex31),fl(Ex31); Trp53+/− mice. The skin of the mice was cut on the 
dorsal side from the base of the tail to the head, and remaining fat 
tissue and blood vessels were removed. The skin was stretched 
with the dermal side faced down and incubated overnight in 
0.25% trypsin at 4°C. The epidermis was separated from the der-
mis, and both were minced and incubated in keratinocyte serum-
free medium (GIBCO Life Technologies, Grand Island, NY) supple-
mented with 50 μg/ml bovine pituitary extract, 5 ng/ml EGF, 100 
U/ml penicillin, and 100 U/ml streptomycin (complete keratinocyte 
medium) for 30 min at 4°C under gentle stirring. Cell suspensions 
were filtered through a cell strainer (70 μm) and centrifuged, and 
dermal and epidermal cells were plated in complete keratinocyte 
medium on collagen I–coated tissue culture plates. After sponta-
neous immortalization, we obtained a keratinocyte cell line named 
OC1. Exon 31 of the plectin gene was subsequently removed from 
these cells by adenovirus-mediated delivery of Cre-recombinase. 
This led to the establishment of various keratinocyte clones ex-
pressing either full-length (clone 12) or rodless (clones 1, 5, and 16) 
plectin. Alternatively, keratinocyte clone OC1 was infected for two 
consecutive rounds with adenovirus containing the gene for either 
GFP or Cre-recombinase. This resulted in the cell lines OC1/GFP 
and OC1/Cre, respectively. Adeno-GFP and Adeno-Cre viruses 
were produced as described previously (Anton and Graham, 1995; 
Luo et al., 2007). More than 95% of the OC1/GFP cells were posi-
tive for GFP expression, as observed by fluorescence microscopy. 
Stable integration of GFP-nesprin-3α and GFP-nesprin-3β was 
performed as described previously (Sterk et al., 2000; Wilhelmsen 
et al., 2005). Briefly, retrovirus carrying the GFP-nesprin-3 con-
structs was produced by calcium phosphate–mediated transfection 
Primer 

























Sequence-specific primers for plectin that are used for PCR analysis of mouse-
tail DNA (P1–P3) and for cloning of the three plectin fragments into pFlexible 
(P4–P9). The position of restriction site tags is indicated by italics.
TABLE 1: Primers used for the generation of rodless plectin mice.
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ing either wild-type or rodless plectin with a novel image analysis 
routine written in ImageJ (National Institutes of Health, Bethesda, 
MD), which will be described in detail elsewhere. Briefly, in each of 
the filamentous structures visible in the images, a curved or wavy 
line was manually drawn through the center of the plectin-positive 
pixels. Lines and the surrounding area (500 nm width) were straight-
ened by affine transformation of the whole image segment using 
the straightening routine in ImageJ and divided into subimages of 
500-nm length. Subsequently the position of the centerlines of the 
different subimages were aligned with subpixel resolution. The dis-
tribution of distances of the labeled plectin and integrin β4 mole-
cules to these lines was then visualized by projecting pixel intensity 
on a line orthogonal to the centerlines. Mean distances were calcu-
lated from these intensity distributions. Approximately 100 filamen-
tous structures were analyzed for each of the two cell types.
Scratch and proliferation assays
Cells were grown to confluence on collagen I–coated 12-well plates, 
and the monolayers were subsequently wounded by scraping with a 
P200 pipette tip. Phase contrast images were acquired at 20-min 
intervals for 24 h using a Zeiss Axiovert 200M inverted microscope 
equipped with an AxioCam MRm Rev.2 camera (Carl Zeiss, Jena, 
Germany). Images were analyzed using ImageJ software. Wound 
closure was defined as the surface area closed per minute. Values 
shown represent the average of three experiments. Comparisons 
were carried out with the Student’s t test. To investigate cell prolif-
eration, cells were seeded in collagen I–coated six-well plates at a 
density of 70,000 cells/well. Cells were trypsinized and counted ev-
ery 24 h for 5 consecutive days.
Lysates, gel filtration chromatography, and chemical 
cross-linking
Cell lysates prepared in NP40 lysis buffer (0.5% Nonidet P40, 150 
mM NaCl, 50 mM Tris-HCl, pH 8.0, protease inhibitor cocktail 
[Sigma-Aldrich, St. Louis, MO]) were subjected to gel filtration chro-
matography on a Superose 6 column (GE Healthcare). Individual 
fractions were collected, separated by SDS–PAGE, and transferred 
to Immobilon-P membranes (Millipore). The presence of plectin was 
determined by immunoblotting. For chemical cross-linking experi-
ments, cells were lysed in lysis buffer (20 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid, pH 7.1, 150 mM NaCl, 4 mM 
EDTA, 1% NP-40, protease inhibitor cocktail) and subjected to 
cross-linkage for 5 min on ice by adding DSP (Pierce) to final con-
centration of 50, 100, or 200 μM. The cross-linking reaction was 
stopped by the addition of Tris-HCl, pH 7.5, to a final concentration 
of 50 mM. Total cell lysates were separated by SDS–PAGE under 
both reducing (5% β-mercaptoethanol; 3–8% gradient gel) and non-
reducing (3.5% gel) conditions and analyzed by immunoblotting for 
plectin. Other cell and tissue lysates were prepared as described 
previously (Ketema et al., 2013).
Blue-native PAGE
Blue-native PAGE was performed using the NativePAGE Novex Bis-
Tris gel system (Invitrogen) according to the instructions provided by 
the manufacturer. Cells were trypsinized and washed in PBS, after 
which the cell pellet was resuspended in lysis buffer consisting of 
either 1× NativePAGE sample buffer (Invitrogen) supplemented with 
1% Triton X-100 or 1× NativePAGE sample buffer supplemented 
with 1% Triton X-100 and 4 M urea. When indicated, SDS was added 
to the samples to a final concentration of 1%. Alternatively, cells 
were lysed in radioimmunoprecipitation buffer consisting of 10 mM 
sodium phosphate, pH 7, 150 mM NaCl, 1% Nonidet P40, 
Alexa Fluor 594, goat anti-rabbit Alexa Fluor 647, and goat anti-rat 
Alexa Fluor 647 were all from Invitrogen. Alexa Fluor 647 phalloidin 
and 4′,6-diamidino-2-phenylindole (DAPI) were purchased from Cell 
Signaling and Sigma-Aldrich, respectively.
Immunohistochemistry
Paraffin embedded sections were deparaffinized, rinsed in water, and 
subjected to antigen retrieval by heating to 95°C in 0.84 M Tris/1 mM 
EDTA, pH 9.0, for 30 min. After cooling for 30 min, sections were 
rinsed in PBS/0.05% Tween 20 (PBS-T) and treated for 20 min with 
3% hydrogen peroxide in methanol to quench endogenous peroxi-
dase activity. Sections were washed in PBS-T and incubated for 30 
min in a blocking solution consisting of 10% milk powder in PBS. 
Thereafter, sections were incubated overnight at 4°C with anti-Ki67 
rabbit pAb diluted 1:600 in PBS/1% BSA/1.25% normal goat serum. 
After additional washes in PBS-T, the sections were incubated for 30 
min with peroxidase-labeled polymer conjugated to goat anti-rabbit 
immunoglobulins (K4009; Dako, Glostrup, Denmark). Sections were 
subsequently rinsed in PBS-T, and the antigen was detected using 
3,3′-diaminobenzidine tetrahydrochloride (D-5905; Sigma-Aldrich). 
Sections were counterstained with hematoxylin, dehydrated, 
mounted in Entellan (Merck Millipore, Darmstadt, Germany), and 
scanned with the Aperio ScanScope XT system (Vista, CA).
Immunofluorescence
Tissue sections were prepared as described previously (Ketema 
et al., 2013). For confocal microscopy, cells were grown on collagen 
I–coated glass coverslips, fixed in 1% paraformaldehyde in PBS for 
15 min, permeabilized with 0.5% Triton X-100 in PBS for 5 min, and 
blocked with 2% BSA in PBS. For superresolution microscopy, we 
used ultraclean coverslips prepared by overnight base and acid in-
cubation. Cells were washed in PBS and incubated for 2 min in 0.3% 
glutaraldehyde/0.25% Triton X-100 in cytoskeleton buffer (CB; 10 
mM 2-(N-morpholino)ethanesulfonic acid, pH 6.1, 150 mM NaCl, 5 
mM ethylene glycol tetraacetic acid, 5 mM MgCl2, 5 mM glucose; 
Auinger and Small, 2008). The cells were subsequently incubated 
for 10 min in 0.5% glutaraldehyde in CB, followed by 7 min in 0.1% 
NaBH4 in PBS. After three washes with PBS, the cells were blocked 
with 5% BSA in PBS. Staining of tissue sections and cells proceeded 
as previously described (Ketema et al., 2013).
Microscopy
Confocal and electron microscopy were conducted as described 
previously (Ketema et al., 2013). Superresolution microscopy was 
performed with a Leica SR GSD microscope (Leica Microsystems, 
Wetzlar, Germany) equipped with an oil immersion objective (HCX 
PL Apo 160×, numerical aperture 1.47) and mounted on a Sumo 
stage (11888963) for drift-free imaging. Images were collected with 
an electron-multiplying charge-coupled device Andor iXon camera 
(Andor Technology, Belfast, United Kingdom). Laser characteristics 
were 405 nm/30 mW, 488 nm/300 mW, and 647 nm/500 mW; the 
405-nm laser was used for backpumping and the others for wide-
field/total internal reflection fluorescence imaging. The number of 
recorded frames varied between 10,000 and 50,000, with a frame 
rate of 100 Hz. The data sets were analyzed using the Thunder Storm 
analysis module (Ovesný et al., 2014). Images were reconstructed 
with a detection threshold of 70 photons, subpixel localization of 
molecules, and uncertainty correction, with a pixel size of 10 nm.
Image analysis
The distribution of distances between the antibody-labeled integrin 
β4 and plectin molecules was determined in keratinocytes express-
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